Evaluation of Ex Vivo Human Immune Response against Candidate Antigens for a Visceral Leishmaniasis Vaccine
Authors:
- Rajiv KumarRKRajiv Kumar
- Yasuyuki GotoYasuyuki Goto
- Kamlesh GidwaniKGKamlesh Gidwani
- Karen D. CowgillKCKaren D. Cowgill
- Shyam SundarSSShyam Sundar
- Steven G. ReedSRSteven G. Reed
- 1 May 2010
- journal article
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 82 (5) , 808-813
Abstract
People cured from visceral leishmaniasis (VL) develop protection mediated by Th1-type cellular responses against new infections. We evaluated cytokine responses against 6 defined candidate vaccine antigens in 15 cured VL subjects and 5 healthy endemic controls with no evidence of previous exposure to Leishmania parasites. Of the 6 cytokines examined, only interferon-gamma (IFN-γ) differentiated cured VL patients from non-exposed individuals, with cured patients mounting a significantly higher IFN-γ response to a crude parasite antigen preparation. Among candidate vaccine antigens tested, the largest number of cured subjects recognized cysteine proteinase B, leading to heightened IFN-γ responses, followed by sterol 24-c-methyltransferase. These two antigens were the most immunogenic and protective antigens in a murine VL model, indicating a relationship between T cell recall responses of humans cured from VL and protective efficacy in an experimental model. Further studies may help prioritize antigens for clinical development of a subunit vaccine against VL.Keywords
This publication has 23 references indexed in Scilit:
- Distinct antigen recognition pattern during zoonotic visceral leishmaniasis in humans and dogsVeterinary Parasitology, 2009
- Immunization with A2 protein results in a mixed Th1/Th2 and a humoral response which protects mice against Leishmania donovani infectionsVaccine, 2001
- Immunization with a Recombinant Stage-Regulated Surface Protein from Leishmania donovani Induces Protection Against Visceral LeishmaniasisThe Journal of Immunology, 2000
- Restoration of IFN-gamma production and lymphocyte proliferation in visceral leishmaniasis.The Journal of Immunology, 1994
- Does lipophosphoglycan enhance the T cell-stimulatory activity of lipophosphoglycan-associated proteins?1994
- Potential role for interleukin-10 in the immunosuppression associated with kala azar.Journal of Clinical Investigation, 1993
- Interleukin 10 production correlates with pathology in human Leishmania donovani infections.Journal of Clinical Investigation, 1993
- Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages.Proceedings of the National Academy of Sciences, 1993
- Tumor necrosis factor and immune interferon synergistically induce cytochrome b-245 heavy-chain gene expression and nicotinamide-adenine dinucleotide phosphate hydrogenase oxidase in human leukemic myeloid cells.Journal of Clinical Investigation, 1989
- Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis.Journal of Clinical Investigation, 1985